Compare HAE & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAE | VIRT |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.4B |
| IPO Year | 1996 | 2014 |
| Metric | HAE | VIRT |
|---|---|---|
| Price | $60.24 | $50.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $84.13 | $44.14 |
| AVG Volume (30 Days) | 531.4K | ★ 1.1M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | 44.54 | ★ 72.73 |
| EPS | 2.46 | ★ 5.13 |
| Revenue | $910,373,000.00 | ★ $3,632,118,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.23 | $2.81 |
| P/E Ratio | $25.16 | ★ $9.87 |
| Revenue Growth | N/A | ★ 26.25 |
| 52 Week Low | $47.32 | $31.55 |
| 52 Week High | $87.32 | $52.21 |
| Indicator | HAE | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 73.11 |
| Support Level | $48.47 | $41.55 |
| Resistance Level | $66.86 | N/A |
| Average True Range (ATR) | 1.87 | 1.47 |
| MACD | 0.70 | 0.42 |
| Stochastic Oscillator | 73.37 | 82.53 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.